KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Other Accumulated Expenses (2016 - 2018)

Historic Other Accumulated Expenses for Idexx Laboratories (IDXX) over the last 9 years, with Q1 2018 value amounting to $65.8 million.

  • Idexx Laboratories' Other Accumulated Expenses rose 1852.55% to $65.8 million in Q1 2018 from the same period last year, while for Mar 2018 it was $65.8 million, marking a year-over-year increase of 1852.55%. This contributed to the annual value of $64.4 million for FY2017, which is 1049.4% down from last year.
  • According to the latest figures from Q1 2018, Idexx Laboratories' Other Accumulated Expenses is $65.8 million, which was up 1852.55% from $64.4 million recorded in Q4 2017.
  • In the past 5 years, Idexx Laboratories' Other Accumulated Expenses registered a high of $72.0 million during Q4 2016, and its lowest value of $44.6 million during Q1 2014.
  • For the 5-year period, Idexx Laboratories' Other Accumulated Expenses averaged around $58.9 million, with its median value being $60.2 million (2015).
  • In the last 5 years, Idexx Laboratories' Other Accumulated Expenses surged by 3803.39% in 2015 and then plummeted by 1133.94% in 2017.
  • Over the past 5 years, Idexx Laboratories' Other Accumulated Expenses (Quarter) stood at $55.7 million in 2014, then rose by 17.99% to $65.7 million in 2015, then increased by 9.62% to $72.0 million in 2016, then fell by 10.49% to $64.4 million in 2017, then grew by 2.18% to $65.8 million in 2018.
  • Its Other Accumulated Expenses stands at $65.8 million for Q1 2018, versus $64.4 million for Q4 2017 and $60.8 million for Q3 2017.